Here, we predicted and then investigated the role of putative HER2 affecting Enhacer1 (so-called Her2-En1) as a regulatory element on the transcriptional balance of short and long variants of HER2 and other interacting genes in breast cancer. This evidence concerns the gene ERBB2 and breast carcinoma.